Designed to Cross the Blood-Brain Barrier: Pharma and the FDA Knew Lipid Nanoparticles Go Everywhere

Designed to Cross the Blood-Brain Barrier: Pharma and the FDA Knew Lipid Nanoparticles Go Everywhere

Dr. Ryan Cole: "It was originally designed to take mRNA and or chemotherapeutic agents to organs that are hard to get to, like the brain... Scientists knew they would not stay in the arm. To have told the people of the world otherwise was a straight up scientific lie."